1
|
Guan D, Dave S, Ebrahim M, Laroche JA. Factors associated with childhood non-vaccination against COVID-19 in Canada: A national survey analysis. Vaccine X 2024; 18:100478. [PMID: 38572339 PMCID: PMC10988031 DOI: 10.1016/j.jvacx.2024.100478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Revised: 02/01/2024] [Accepted: 03/18/2024] [Indexed: 04/05/2024] Open
Abstract
Background COVID-19 vaccination efforts are critical in mitigating the impact of the virus, but despite proven safety and efficacy, vaccination rates among children in Canada are lower than in adults, prompting a need to explore determinants of childhood COVID-19 non-vaccination to improve uptake. Method This study analyzed data from the Canadian COVID-19 Immunization Coverage Survey 2022. Using multivariable logistic regression, it examined the association between COVID-19 non-vaccination among children aged 5-17 and factors such as parental sociodemographic characteristics, vaccine knowledge, attitudes, and beliefs (KAB), and vaccination history. Results The analysis revealed that negative KAB towards vaccines, reflected in higher KAB composite scores, significantly increased the likelihood of non-vaccination. Additionally, factors such as lower household incomes, rural residence, employment in sectors not at risk for vaccine-preventable diseases, and younger parental age were associated with higher non-vaccination. The study also highlighted ethnic disparities in vaccination odds and found that children with incomplete routine vaccinations or inconsistent flu vaccination histories were more likely to be unvaccinated against COVID-19. Surprisingly, children of parents who consistently received flu vaccinations were more likely to be unvaccinated against COVID-19. Furthermore, parental education levels showed a complex relationship with children's COVID-19 vaccination status, indicating nuanced influences on vaccination decisions. Conclusion The findings offer vital insights into the factors influencing COVID-19 vaccination uptake among children in Canada, suggesting avenues for targeted strategies to improve vaccine coverage.
Collapse
Affiliation(s)
- David Guan
- Centre for Immunization Surveillance, Public Health Agency of Canada, Ottawa, Ontario, Canada
| | - Sailly Dave
- Centre for Immunization Surveillance, Public Health Agency of Canada, Ottawa, Ontario, Canada
| | - Marwa Ebrahim
- Centre for Immunization Surveillance, Public Health Agency of Canada, Ottawa, Ontario, Canada
| | - Julie A. Laroche
- Centre for Immunization Surveillance, Public Health Agency of Canada, Ottawa, Ontario, Canada
| |
Collapse
|
2
|
Strafford H, Hollinghurst J, Lacey AS, Akbari A, Watkins A, Paterson J, Jennings D, Lyons RA, Powell HR, Kerr MP, Chin RF, Pickrell WO. Epilepsy and the risk of COVID-19-related hospitalization and death: A population study. Epilepsia 2024; 65:1383-1393. [PMID: 38441374 DOI: 10.1111/epi.17910] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Revised: 01/24/2024] [Accepted: 01/24/2024] [Indexed: 03/14/2024]
Abstract
OBJECTIVE People with epilepsy (PWE) may be at an increased risk of severe COVID-19. It is important to characterize this risk to inform PWE and for future health and care planning. We assessed whether PWE were at higher risk of being hospitalized with, or dying from, COVID-19. METHODS We performed a retrospective cohort study using linked, population-scale, anonymized electronic health records from the SAIL (Secure Anonymised Information Linkage) databank. This includes hospital admission and demographic data for the complete Welsh population (3.1 million) and primary care records for 86% of the population. We identified 27 279 PWE living in Wales during the study period (March 1, 2020 to June 30, 2021). Controls were identified using exact 5:1 matching (sex, age, and socioeconomic status). We defined COVID-19 deaths as having International Classification of Diseases, 10th Revision (ICD-10) codes for COVID-19 on death certificates or occurring within 28 days of a positive SARS-CoV-2 polymerase chain reaction (PCR) test. COVID-19 hospitalizations were defined as having a COVID-19 ICD-10 code for the reason for admission or occurring within 28 days of a positive SARS-CoV-2 PCR test. We recorded COVID-19 vaccinations and comorbidities known to increase the risk of COVID-19 hospitalization and death. We used Cox proportional hazard models to calculate hazard ratios. RESULTS There were 158 (.58%) COVID-19 deaths and 933 (3.4%) COVID-19 hospitalizations in PWE, and 370 (.27%) deaths and 1871 (1.4%) hospitalizations in controls. Hazard ratios for COVID-19 death and hospitalization in PWE compared to controls were 2.15 (95% confidence interval [CI] = 1.78-2.59) and 2.15 (95% CI = 1.94-2.37), respectively. Adjusted hazard ratios (adjusted for comorbidities) for death and hospitalization were 1.32 (95% CI = 1.08-1.62) and 1.60 (95% CI = 1.44-1.78). SIGNIFICANCE PWE are at increased risk of being hospitalized with, and dying from, COVID-19 when compared to age-, sex-, and deprivation-matched controls, even when adjusting for comorbidities. This may have implications for prioritizing future COVID-19 treatments and vaccinations for PWE.
Collapse
Affiliation(s)
- Huw Strafford
- Faculty of Medicine, Health, and Life Science, Swansea University Medical School, Swansea University, Swansea, UK
| | - Joe Hollinghurst
- Faculty of Medicine, Health, and Life Science, Swansea University Medical School, Swansea University, Swansea, UK
| | - Arron S Lacey
- Faculty of Medicine, Health, and Life Science, Swansea University Medical School, Swansea University, Swansea, UK
| | - Ashley Akbari
- Faculty of Medicine, Health, and Life Science, Swansea University Medical School, Swansea University, Swansea, UK
| | - Alan Watkins
- Faculty of Medicine, Health, and Life Science, Swansea University Medical School, Swansea University, Swansea, UK
| | | | | | - Ronan A Lyons
- Faculty of Medicine, Health, and Life Science, Swansea University Medical School, Swansea University, Swansea, UK
| | - H Robert Powell
- Faculty of Medicine, Health, and Life Science, Swansea University Medical School, Swansea University, Swansea, UK
- Morriston Hospital, Swansea Bay University Health Board, Swansea, UK
| | - Michael P Kerr
- Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, UK
| | - Richard F Chin
- Muir Maxwell Epilepsy Centre, Centre for Clinical Brain Sciences and Department of Child Life and Health, University of Edinburgh, Edinburgh, UK
- Royal Hospital for Children and Young People, Edinburgh, UK
| | - William O Pickrell
- Faculty of Medicine, Health, and Life Science, Swansea University Medical School, Swansea University, Swansea, UK
- Morriston Hospital, Swansea Bay University Health Board, Swansea, UK
| |
Collapse
|
3
|
Nguyen SN, Vu LT, Nguyen HT, Dao GH, Nguyen ANT. Clinical Epidemiological Characteristics and Risk Factors for Severity of SARS-CoV-2 Pneumonia in Pediatric Patients: A Hospital-Based Study in Vietnam. Cureus 2024; 16:e58371. [PMID: 38756320 PMCID: PMC11097285 DOI: 10.7759/cureus.58371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/14/2024] [Indexed: 05/18/2024] Open
Abstract
Introduction Coronavirus disease (COVID-19) is an infectious disease caused by SARS-CoV-2, which can cause organ failure in several organs, cardiac problems, or acute respiratory distress syndrome (ARDS). Identifying clinical epidemiological characteristics and risk factors for complications of COVID-19 allows clinicians to diagnose and treat promptly. Objectives This study aims to describe the clinical epidemiological characteristics of COVID-19 and assess risk factors for the severity of SARS-CoV-2 pneumonia in children treated at Haiphong Children's Hospital. Methods A descriptive cross-sectional study was conducted in Haiphong Children's Hospital, Haiphong, Vietnam, for one year, from January 1, 2022, to December 31, 2022. Results In our study, 540 children were evaluated; the male-to-female ratio was 1.48/1; the median age was 23 months (IQR=6-74); Children aged under one year accounted for the highest proportion (n=202; 37.4%); 40 (7.4%) children had underlying illnesses. The number of admitted patients diagnosed with COVID-19 peaked in February 2022. Regarding severity, 380 (70.4%) cases were mild, 136 (25.2%) were moderate, only 24 (4.4%) cases were severe, and no children died. Common symptoms were fever in 483 (89.4%), coughing in 399 (73.9%), and tachypnea in 163 (30.2%) children. Laboratory features: white blood cell count, platelet count, serum CRP, and coagulation test showed little change. Around 116 (21.5%) had lymphopenia and 148 (27.4%) had pneumonia. Patients under one year were approximately 1.64 times more likely to experience pneumonia complications from COVID-19 than those without such a history (OR=1.64, 95%CI = 1.12 - 2.41, p=0.0112). Patients with underlying conditions were approximately 2.08 times more likely to experience pneumonia complications from COVID-19 compared to those without such conditions (OR=2.08, 95%CI =1.08 - 4.02, p=0.0289). Conclusion In COVID-19 pediatric patients, the severity of the disease was mild to moderate without any mortality. Children aged under one year accounted for the highest proportion of all COVID-19 patients. This study found that age under one year and underlying illnesses are related to pneumonia in COVID-19 pediatric patients.
Collapse
Affiliation(s)
- Sang N Nguyen
- Pediatrics, Haiphong University of Medicine and Pharmacy, Haiphong, VNM
| | - Lam T Vu
- Pediatrics, Haiphong University of Medicine and Pharmacy, Haiphong, VNM
| | - Ha T Nguyen
- Otolaryngology, Hanoi Medical University, Hanoi, VNM
| | - Giang H Dao
- Pediatrics, Haiphong University of Medicine and Pharmacy, Haiphong, VNM
| | - Anh Ngoc T Nguyen
- Pediatrics, Haiphong University of Medicine and Pharmacy, Haiphong, VNM
| |
Collapse
|
4
|
Leite RO, Brodar KE, Saab PG, Marchetti D, Jaramillo M, Sanchez J, Davis E, Delamater AM, La Greca AM. Diabetes Care and Mental Health During the COVID-19 Pandemic: Perspectives of Adolescents with Diabetes, Parents, and Providers. J Clin Psychol Med Settings 2024:10.1007/s10880-023-09995-9. [PMID: 38281304 DOI: 10.1007/s10880-023-09995-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/04/2023] [Indexed: 01/30/2024]
Abstract
This study explored ways in which the COVID-19 pandemic impacted adolescents' diabetes management and psychosocial functioning, and how adolescents, parents, and providers viewed telemedicine. We present data from three studies: (1) a comparison of psychosocial functioning and glycemic levels before and after pandemic onset (n = 120 adolescents; 89% with type 1 diabetes), (2) an online survey of parents about pandemic-related stressors (n = 141), and (3) qualitative interviews with adolescents, parents, and medical providers about the pandemic's impacts on adolescents' diabetes care and mental health (n = 13 parent-adolescent dyads; 7 medical providers). Results suggested some adverse effects, including disrupting routines related to health behaviors and psychosocial functioning and impairing adolescents' quality of life. Despite these challenges, most participants did not endorse significant impacts. Some even noted benefits, such as increased parental supervision of diabetes management that can be leveraged beyond the pandemic. Furthermore, telemedicine offers benefits to continuity of diabetes care but presents challenges to care quality. These findings underscore the varied and unique impacts of the COVID-19 pandemic on adolescents with diabetes.
Collapse
Affiliation(s)
- Rafael O Leite
- Department of Psychology, University of Miami, 5665 Ponce de Leon Blvd., Flipse Building 420, Coral Gables, FL, 33136, USA.
| | | | - Patrice G Saab
- Department of Psychology, University of Miami, 5665 Ponce de Leon Blvd., Flipse Building 420, Coral Gables, FL, 33136, USA
| | - Daniella Marchetti
- Psychology Service, Bruce W. Carter Medical Center, Miami VA Healthcare System, Miami, FL, USA
| | - Manuela Jaramillo
- Department of Psychology, University of Miami, 5665 Ponce de Leon Blvd., Flipse Building 420, Coral Gables, FL, 33136, USA
| | - Janine Sanchez
- Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Eileen Davis
- Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Alan M Delamater
- Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Annette M La Greca
- Department of Psychology, University of Miami, 5665 Ponce de Leon Blvd., Flipse Building 420, Coral Gables, FL, 33136, USA
| |
Collapse
|
5
|
Pediatricians’ Perceptions, Practices, and Barriers Regarding COVID-19 Vaccine for Children: A Cross-Sectional Survey in Ontario, Canada. Vaccine 2023; 41:3058-3065. [PMID: 37045681 PMCID: PMC10067459 DOI: 10.1016/j.vaccine.2023.03.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 03/03/2023] [Accepted: 03/21/2023] [Indexed: 04/05/2023]
Abstract
Background SARS-CoV-2 vaccination of all age-eligible populations is an important part of the COVID-19 pandemic response. In Ontario, vaccination coverage in 5-to-11-year-old children has remained lower than in other age groups. We sought to understand pediatricians’ perception, practices, and barriers to SARS-CoV-2 vaccination in children, particularly children aged 5-to-11 years, to inform interventions and promote capacity of pediatricians as vaccinators and vaccination promoters. Methods This is a descriptive, cross-sectional study consisting of an online self-administered questionnaire distributed to 1,313 pediatricians in Ontario. Descriptive statistics, including Chi-square or Fisher’s exact tests, were performed. Results In total, 152 Pediatricians responded (11.6% response rate), from February 17, 2022 to March 17, 2022. 78% of respondents were general pediatricians and 22% were pediatric subspecialists. Median years of practice was 17 (8-31), with 68% female, 32% male. Most pediatricians thought it was unlikely that children aged 5-to-11 years would become seriously ill from acute COVID-19 caused by Delta (66%) or Omicron (80%). 92% were very likely to recommend the COVID-19 vaccine for children aged 5-to-11 years. COVID-19 vaccine was perceived as safe, with higher safety perception in children aged 5-to-11 compared to 12-to-17 years (p<0.0001). COVID-19 vaccines were thought to be effective in reducing hospitalization or severe illness, and reducing SARS-CoV-2 infection, with higher perceived effectiveness against Delta compared to Omicron (p<0.0001). 97% felt confident counselling caregivers of children aged 5-to-11 years on the COVID-19 vaccine. Few pediatricians did not feel confident in accessing resources for health professionals (6%) or for patients/caregivers (12%). Conclusions Most surveyed pediatricians were very likely to recommend COVID-19 vaccination for children aged 5-to-11-years, perceived COVID-19 vaccines as safe and effective, and felt confident in their COVID-19 vaccine counselling for children aged 5-to-11 years. However, there remains areas for further training and capacity development.
Collapse
|
6
|
Farrar D, Hepburn CM, Drouin O, El Tal T, Morin MP, Berard R, King M, Thibodeau ML, Baerg K, Beaudoin-Bussières G, Beaufils C, Bennett TL, Benseler S, Chan K, Cyr C, Dahdah N, Donner E, Embree J, Farrell C, Finzi A, Forgie S, Giroux R, Kang K, Lang B, Laxer R, McCrindle B, Orkin J, Papenburg J, Pound C, Price V, Proulx-Gauthier JP, Purewal R, Sadarangani M, Salvadori M, Thibeault R, Top K, Viel-Thériault I, Haddad E, Scuccimarri R, Yeung R, Kakkar F, Morris S. Resource use and disease severity of children hospitalized for COVID-19 versus multisystem inflammatory syndrome in children (MIS-C) in Canada. CANADA COMMUNICABLE DISEASE REPORT = RELEVE DES MALADIES TRANSMISSIBLES AU CANADA 2023; 49:103-112. [PMID: 38356877 PMCID: PMC10866613 DOI: 10.14745/ccdr.v49i04a03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/16/2024]
Abstract
Background Direct comparisons of paediatric hospitalizations for acute coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C) can inform health system planning. We describe the absolute and relative hospital burden of acute paediatric COVID-19 and MIS-C in Canada. Methods This national prospective study was conducted via the Canadian Paediatric Surveillance Program from March 2020-May 2021. Children younger than 18 years old and hospitalized for acute COVID-19 or MIS-C were included in the analysis. Outcomes included supplemental oxygen (low-flow oxygen or high-flow nasal cannula), ventilation (non-invasive or conventional mechanical), vasopressors, paediatric intensive care unit (PICU) admission, or death. Adjusted risk differences (aRD) and 95% confidence intervals (CI) were calculated to identify factors associated with each diagnosis. Results Overall, we identified 330 children hospitalized for acute COVID-19 (including five deaths) and 208 hospitalized for MIS-C (including zero deaths); PICU admission was required for 49.5% of MIS-C hospitalizations versus 18.2% of acute COVID-19 hospitalizations (aRD 20.3; 95% CI, 9.9-30.8). Resource use differed by age, with children younger than one year hospitalized more often for acute COVID-19 (aRD 43.4% versus MIS-C; 95% CI, 37.7-49.1) and more children 5-11 years hospitalized for MIS-C (aRD 38.9% vs. acute COVID-19; 95% CI, 31.0-46.9). Conclusion While there were more hospitalizations and deaths from acute paediatric COVID-19, MIS-C cases were more severe, requiring more intensive care and vasopressor support. Our findings suggest that both acute COVID-19 and MIS-C should be considered when assessing the overall burden of severe acute respiratory syndrome coronavirus 2 in hospitalized children.
Collapse
Affiliation(s)
- Daniel Farrar
- Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON
| | - Charlotte Moore Hepburn
- Division of Paediatric Medicine, The Hospital for Sick Children, Toronto, ON
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON
| | - Olivier Drouin
- Division of General Paediatrics, Department of Paediatrics, CHU Sainte-Justine, Montréal, QC
- Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, QC
| | - Tala El Tal
- Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, ON
| | - Marie-Paule Morin
- Division of Paediatric Rheumatology-Immunology, CHU Sainte-Justine, Department of Paediatrics, University of Montreal, Montréal, QC
| | - Roberta Berard
- Division of Rheumatology, Department of Paediatrics, Children’s Hospital at London Health Sciences Centre, London, ON
| | - Melanie King
- Canadian Paediatric Surveillance Program, Canadian Paediatric Society, Ottawa, ON
| | | | - Krista Baerg
- Department of Paediatrics, University of Saskatchewan, Saskatoon, SK
- Division of General Paediatrics, Jim Pattison Children’s Hospital, Saskatchewan Health Authority, Saskatoon, SK
| | - Guillaume Beaudoin-Bussières
- Centre de Recherche du CHUM et Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC
| | - Camille Beaufils
- Division of Paediatric Rheumatology-Immunology, CHU Sainte-Justine, Department of Paediatrics, University of Montreal, Montréal, QC
| | | | - Susanne Benseler
- Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB
- Division of Rheumatology, Department of Paediatrics, Alberta Children’s Hospital, University of Calgary, Calgary, AB
| | - Kevin Chan
- Department of Paediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON
- Department of Children’s and Women’s Health, Trillium Health Partners, Mississauga, ON
- Institute for Better Health, Trillium Health Partners, Mississauga, ON
| | - Claude Cyr
- Service de Soins Intensifs Pédiatriques, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC
| | - Nagib Dahdah
- Division of Paediatric Cardiology, CHU Sainte-Justine, Department of Paediatrics, University of Montréal, Montréal, QC
| | - Elizabeth Donner
- Department of Paediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON
- Division of Neurology, The Hospital for Sick Children, Toronto, ON
| | - Joanne Embree
- Department of Paediatrics and Child Health, University of Manitoba, Winnipeg, MB
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB
| | - Catherine Farrell
- Division of Paediatric Intensive Care, Department of Paediatrics, CHU Sainte-Justine, Montréal, QC
| | - Andrés Finzi
- Centre de Recherche du CHUM et Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC
| | - Sarah Forgie
- Division of Infectious Diseases, Department of Paediatrics, University of Alberta, Edmonton, AB
- Stollery Children’s Hospital, Edmonton, AB
| | - Ryan Giroux
- Women’s and Children’s Health Program, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON
| | - Kristopher Kang
- Department of Paediatrics, University of British Columbia, Vancouver, BC
| | - Bianca Lang
- Division of Rheumatology, Department of Paediatrics, Dalhousie University, Halifax, NS
| | - Ronald Laxer
- Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, ON
- Department of Paediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON
| | - Brian McCrindle
- The Labatt Family Heart Centre, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, ON
| | - Julia Orkin
- Division of Paediatric Medicine, The Hospital for Sick Children, Toronto, ON
- Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON
| | - Jesse Papenburg
- Division of Paediatric Infectious Diseases, Department of Paediatrics, Montreal Children’s Hospital, Montréal, QC
- Division of Microbiology, Department of Clinical Laboratory Medicine, McGill University Health Centre, Montréal, QC
| | - Catherine Pound
- Division of Consulting Paediatrics, Department of Paediatrics, Children’s Hospital of Eastern Ontario, Ottawa, ON
| | - Victoria Price
- Division of Paediatric Hematology/Oncology, Department of Paediatrics, Dalhousie University, Halifax, NS
| | | | - Rupeena Purewal
- Department of Paediatrics, University of Saskatchewan, Saskatoon, SK
- Division of Paediatric Infectious Diseases, Jim Pattison Children’s Hospital, Saskatchewan Health Authority, Saskatoon, SK
| | - Manish Sadarangani
- Department of Paediatrics, University of British Columbia, Vancouver, BC
- Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, BC
| | | | - Roseline Thibeault
- Division of Infectious Diseases, Department of Paediatrics, CHU de Québec-Université Laval, Québec City, QC
| | - Karina Top
- Department of Paediatrics, Dalhousie University, Halifax, NS
| | - Isabelle Viel-Thériault
- Division of Infectious Diseases, Department of Paediatrics, CHU de Québec-Université Laval, Québec City, QC
| | - Elie Haddad
- Division of Paediatric Rheumatology-Immunology, CHU Sainte-Justine, Department of Paediatrics, University of Montreal, Montréal, QC
| | - Rosie Scuccimarri
- Division of Paediatric Rheumatology, Montreal Children’s Hospital and McGill University Health Centre, Montréal, QC
| | - Rae Yeung
- Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, ON
- Cell Biology Program, The Hospital for Sick Children, Toronto, ON
- Department of Immunology and Institute of Medical Science, University of Toronto, Toronto, ON
| | - Fatima Kakkar
- Division of Infectious Diseases, CHU Sainte-Justine, Montréal, QC
| | - Shaun Morris
- Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON
- Department of Paediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON
- Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON
- Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Toronto, ON
| |
Collapse
|
7
|
Piché-Renaud PP, Karimi-Shahrbabak E, Abu Fadaleh S, Farrar D, Orkin J, Science M, Morris S. SARS-CoV-2 vaccine acceptance among caregivers of children younger than five years of age: A cross-sectional survey in Toronto. CANADA COMMUNICABLE DISEASE REPORT = RELEVE DES MALADIES TRANSMISSIBLES AU CANADA 2023; 49:127-132. [PMID: 38371854 PMCID: PMC10871738 DOI: 10.14745/ccdr.v49i04a05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 02/20/2024]
Abstract
Background Despite severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine approval in Canada for children six months to five years old, vaccine acceptance for this age group remains low compared with other age groups. This study aimed to assess vaccine acceptance among caregivers of children younger than five years old and to identify factors associated with SARS-CoV-2 vaccine hesitancy in Toronto. Methods A multi-language self-administered survey was sent to caregivers of children attending 660 Toronto schools and two community health centres between April 5 to July 4, 2022. Data on socio-demographic characteristics, acceptance of routine childhood and influenza vaccines and current SARS-CoV-2 vaccine status for parents and older siblings were collected. Results A total of 253 caregivers of children younger than five years old answered the survey. Although 234 (94%) of the responding caregivers were fully vaccinated against SARS-CoV-2 and more than 90% had their children older than five years receiving one dose of the vaccine, only 148 (59%) had intentions to vaccinate their child younger than five years old. Conclusion These findings highlight the importance of interventions to increase vaccine confidence among caregivers of children aged younger than five years old.
Collapse
Affiliation(s)
- Pierre-Philippe Piché-Renaud
- Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON
- Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON
| | | | - Sarah Abu Fadaleh
- Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON
| | - Daniel Farrar
- Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON
| | - Julia Orkin
- Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON
- Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON
| | - Michelle Science
- Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON
- Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON
| | - Shaun Morris
- Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON
- Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON
- Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON
- Division of Clinical Public Health and Centre for Vaccine Preventable Diseases, Dalla Lana School of Public Health, Toronto, ON
| |
Collapse
|
8
|
Factors Associated with Willingness to Receive a COVID-19 Vaccine in Adult Polish Population-A Cross-Sectional Survey. Vaccines (Basel) 2022; 10:vaccines10101715. [PMID: 36298579 PMCID: PMC9609836 DOI: 10.3390/vaccines10101715] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Revised: 10/11/2022] [Accepted: 10/12/2022] [Indexed: 11/23/2022] Open
Abstract
Vaccinations are proven to be the most efficient in preventing COVID-19 disease. Nonetheless, some people are skeptical and hesitant. The study aimed to determine factors associated with willingness to receive a COVID-19 vaccine in the Polish adult population. An online survey consisting of questions regarding (1) demographic information and (2) health issues (the status of vaccination, comorbidities, receiving the flu vaccine and usage of health monitoring apps) was distributed between 13 January and 14 February 2022. Of the 7018 participants who met the study conditions, 76.89% (n = 5396) were females, 22.44% (n = 1575) were males and 0.67% (n = 47) did not specify gender. The median age was 31 years. Among them, 81.82% (n = 5742) were vaccinated and 18.18% (n = 1276) were not. 46.87% (n = 3289) had no chronic co-morbidities. Factors associated with lower odds to receive the vaccine were: being men (p = 0.02; OR = 0.83), having lower education status (p = 0.001, OR = 0.56−0.77), living in a smaller residence area (p < 0.001, OR = 0.47−0.73.), not receiving flu vaccination (p < 0.001, OR = 24.51) and not using health monitoring applications (p < 0.001, OR = 1.56). Health education and communication strategies are needed to achieve large-scale vaccine acceptability and finally herd immunity.
Collapse
|